α-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients

被引:49
作者
Hücking, K
Kostic, Z
Pox, C
Ritzel, R
Holst, JJ
Schmiegel, W
Nauck, MA
机构
[1] Diabet Zentrum Bad Lauterberg, D-37431 Bad Lauterberg im Harz, Germany
[2] Knappschaftskrankenhaus Bochum Langendreer, Med Univ Klin, Bochum, Germany
[3] Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen, Denmark
关键词
alpha-glucosidase inhibition; acarbose; GIP; GLP-1 (7-36 amide); hyperglycaemia; incretin hormones; insulin secretion; type; 2-diabetes;
D O I
10.1111/j.1464-5491.2005.01451.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim Acarbose is able to enhance GLP-1 release and delay gastric emptying in normal subjects. The effect of alpha-glucosidase inhibition on GLP-1 has been less evident in Type 2 diabetic patients. The aim of this study was to investigate the possible influence of acarbose on GLP-1 release and gastric emptying in Type 2 diabetic patients after a mixed test meal. Patients and methods Ten Type 2 diabetic patients were tested with 100 mg acarbose or placebo served with a mixed meal that was labelled with 100 mg C-13-octanoic acid. Plasma concentrations of glucose, insulin, C-peptide, glucagon, GLP-1 and GIP were determined over 6 h. Gastric emptying was measured by determining breath (CO2)-C-13 using infrared absorptiometry. Statistics repeated-measures ANOVA. Results Gastric emptying rates (t(1/2): 162 +/- 45 vs. 163 +/- 62 min, P = 0.65) and plasma concentrations (increasing from approximate to 12 to approximate to 25 pmol/l, P = 0.37) and integrated responses of GLP-1 (P = 0.37) were not changed significantly by acarbose treatment. Postprandial plasma glucose concentrations (P < 0.0001) and their integrated responses were lowered by acarbose (by 64%; P = 0.016). The plasma concentrations of insulin and C-peptide were reduced (P = 0.007 and 0.057, respectively) by acarbose, while glucagon was not changed (P = 0.96). GIP plasma concentrations (increasing with placebo from approximate to 10 to approximate to 85 pmol/l and with acarbose to approximate to 55 pmol/l (P < 0.0001) and their integrated responses were significantly lowered (by 43%) by acarbose (P = 0.021). After 2 weeks of acarbose treatment (50 mg t.i.d. for the first and 100 mg t.i.d. for the second week, n = 6), similar results were found. conclusions In hyperglycaemic Type 2 diabetic patients, ingestion of acarbose with a mixed test meal failed to enhance GLP-1 release and did not influence gastric emptying.
引用
收藏
页码:470 / 476
页数:7
相关论文
共 40 条
[1]   ACARBOSE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL [J].
CLISSOLD, SP ;
EDWARDS, C .
DRUGS, 1988, 35 (03) :214-243
[2]   GUT HORMONES AND DIABETES-MELLITUS [J].
CREUTZFELDT, W ;
NAUCK, M .
DIABETES-METABOLISM REVIEWS, 1992, 8 (02) :149-177
[3]   GLUCAGON-LIKE PEPTIDE-1 CELLS IN THE GASTROINTESTINAL-TRACT AND PANCREAS OF RAT, PIG AND MAN [J].
EISSELE, R ;
GOKE, R ;
WILLEMER, S ;
HARTHUS, HP ;
VERMEER, H ;
ARNOLD, R ;
GOKE, B .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (04) :283-291
[4]  
FOLWACZNY C, 1995, Z GASTROENTEROL, V33, P517
[5]   MECHANISM OF ACCELERATED GASTRIC-EMPTYING OF LIQUIDS AND HYPERGLYCEMIA IN PATIENTS WITH TYPE-II DIABETES-MELLITUS [J].
FRANK, JW ;
SASLOW, SB ;
CAMILLERI, M ;
THOMFORDE, GM ;
DINNEEN, S ;
RIZZA, RA .
GASTROENTEROLOGY, 1995, 109 (03) :755-765
[6]   MEASUREMENT OF GASTRIC-EMPTYING RATE OF SOLIDS BY MEANS OF A CARBON-LABELED OCTANOIC-ACID BREATH TEST [J].
GHOOS, YF ;
MAES, BD ;
GEYPENS, BJ ;
MYS, G ;
HIELE, MI ;
RUTGEERTS, PJ ;
VANTRAPPEN, G .
GASTROENTEROLOGY, 1993, 104 (06) :1640-1647
[7]   VOGLIBOSE (AO-128) IS AN EFFICIENT ALPHA-GLUCOSIDASE INHIBITOR AND MOBILIZES THE ENDOGENOUS GLP-1 RESERVE [J].
GOKE, B ;
FUDER, H ;
WIECKHORST, G ;
THEISS, U ;
STRIDDE, E ;
LITTKE, T ;
KLEIST, P ;
ARNOLD, R ;
LUCKER, PW .
DIGESTION, 1995, 56 (06) :493-501
[8]   REGULATION OF GLUCAGON-LIKE PEPTIDE-1 SECRETION FROM RAT ILEUM BY NEUROTRANSMITTERS AND PEPTIDES [J].
HERRMANNRINKE, C ;
VOGE, A ;
HESS, M ;
GOKE, B .
JOURNAL OF ENDOCRINOLOGY, 1995, 147 (01) :25-31
[9]   A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (UK Prospective Diabetes Study 44) [J].
Holman, RR ;
Cull, CA ;
Turner, RC .
DIABETES CARE, 1999, 22 (06) :960-964